Compare Las Vegas Sands Corp. (LVS) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Las Vegas Sands Corp. vs Teladoc Health Inc — how do they compare? Las Vegas Sands Corp. trades at $36.17 (market cap $23.38B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Las Vegas Sands Corp. is far larger — about 23.1× Teladoc Health Inc's market cap, and Las Vegas Sands Corp. pays a 3.32% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Las Vegas Sands Corp. for 72 Days and Teladoc Health Inc for 39 Days on average.
| LVS | TDOC | |
|---|---|---|
Market Cap | $23.38B | $1.01B |
Volume | 6,994,661 | 4,668,477 |
Sector | Consumer Cyclical | Health |
52-Week High | $69.49 | $9.72 |
52-Week Low | $35.81 | $4.47 |
Typical Hold Time | 72 Days | 39 Days |
Enterprise Value | $35.27B | $1.27B |
Dividend Yield | 3.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LVS trades at $36.10, up 0.81% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. Fundamentally, the company shows strong profitability with a 12.59% net margin and consistent revenue growth, reaching $13.02B in 2025. Recent earnings have been mixed, with a Q2 2026 miss after two prior beats. Analyst sentiment remains positive with a 59% buy rating and a $59.78 consensus price target, implying significant upside. The company maintains robust cash flow from operations of $3.02B in 2025.
The outlook for LVS is cautiously optimistic, driven by solid fundamentals and analyst confidence, but weighed by technical weakness and high debt levels. Investment opportunity lies in the substantial discount to price targets, while risks include leverage, Macao regulatory exposure, and volatile earnings. The stock's current valuation multiples, such as a P/E of 13.99, appear attractive if operational execution continues.
Teladoc Health (TDOC) trades at $5.54, down 0.36% on the day, as the stock faces bearish technical momentum despite recent earnings beats. The company maintains strong revenue around $2.5B annually but continues to report net losses, with a -7.13% net income margin in 2026. Analyst sentiment is mixed with 35.7% buy ratings but a consensus price target of $8.83 suggesting 59% upside potential. Recent CFO appointment and legal officer transitions signal management changes amid ongoing operational challenges.
TDOC presents a high-risk opportunity with significant valuation discount (P/S 0.4x) but faces persistent profitability challenges. The integrated care business shows promise with improving margins, while BetterHelp weakness and negative cash flow in 2025 raise concerns. Upside depends on successful execution of turnaround strategy and achieving sustainable profitability in the competitive telehealth market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
